Study of QL2302 vs Tezspire in healthy volunteers
This trial tests a new medicine (QL2302) to see how it moves through the body and to check its safety in healthy people. It compares QL2302 to Tezspire, an approved medicine for severe asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You weigh between 50 and 85 kg (about 110 to 187 pounds) and have a BMI between 19 and 26.
- You are generally healthy, with no major medical conditions, and have not had an allergic reaction to the study drug or similar drugs.
- You do not smoke more than 5 cigarettes a day, do not have a history of heavy alcohol use or drug abuse, and have not donated blood recently.
- You are willing to avoid pregnancy (if applicable), not donate sperm, and follow contraception rules during the study.
- You have not taken certain medications (prescription, over-the-counter, or herbal) or vaccines in the last few weeks, and have no infections or other exclusionary health issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
This trial tests a new medicine, QL2302, to see how well it works compared to an approved treatment called Tezspire for people with severe asthma. If you have asthma that is not well controlled despite using daily inhalers and other medications, you may be able to join.
This study is testing a new medicine called ZL-1503 in healthy volunteers to see how the body processes it and if it's safe. You may be able to join if you are in good health and meet certain age, weight, and lifestyle requirements.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.